Middle East and Africa PCR for Respiratory Infection Diagnostics Market

Market Introduction

Polymerase chain reaction (PCR) is used for accurate point of care diagnostics that help rapidly identify and determine the cause of respiratory tract infections. In addition, PCR is widely preferred in inpatient and outpatient settings that help enhance the growth of the market in recent years.

Market Overview and Dynamics

The Middle East and Africa PCR for respiratory infection diagnostics market is expected to reach US$ 1,515.94 million by 2028 from US$ 737.47 million in 2021; it is estimated to grow at a CAGR of 8.6% from 2021 to 2028. The growth of the market is attributed to some of the key driving factors, such as increasing burden of chronic respiratory diseases (CRDs) and increasing use of PCR testing for various respiratory infection diagnostics. However, availability of alternative assays is the major factor hindering the market growth.

Chronic respiratory diseases (CRDs) are among the leading causes of morbidity globally due to the heavy consumption of tobacco. For instance, according to the National Health Services, in England, nearly one in five people is affected by a respiratory disease, and respiratory diseases is the third leading cause of deaths. The burden of CRDs is expected to increase in the future due to poor air quality, addiction to smoking, and rise in geriatric population is more prone to COPD and lung cancer. Moreover, programs initiated in the countries to improve treatment and support the people living with respiratory diseases are likely to increase the demand for PCR for the diagnosis of respiratory diseases. This will lead to the market growth during the forecast period. PCR testing is the gold standard for detecting respiratory infectious diseases, including SARS-CoV-2. Also, the growing developments in PCR are not limited to the COVID-19 testing. The continuous technological developments have allowed researchers to develop advanced PCR techniques at a reduced cost and limit their complexities. In addition, PCR testing is significantly used in institutions such as nursing homes, chronic care facilities, and hospitals for identifying influenza virus infection that causes respiratory outbreaks. Therefore, various companies are offering PCR kits that can detect the presence of pathogens that cause respiratory diseases. Apart from the increasing incidence of acute and chronic respiratory diseases, other factors such as environmental and climatic conditions, air pollution, and discoveries of novel bacteria, viruses, and pathogens are likely to serve as vital growth opportunities for PCR testing for respiratory infection diagnostics in the future.

The Middle Eastern economy is seriously hit due to the exponential growth of COVID-19 cases in the region. The rising occurrence rate of coronavirus results in increased stress on the region's healthcare system, which is also rising the demand for diagnostic tests in its healthcare system, supporting the expansion of the sector in this region. Several manufacturers are developing advanced PCR test kits and systems for the detection of the novel COVID-19 virus. As the coronavirus increases, millions of people will need testing. Thus, high throughput molecular testing is expected to play a central role in the future management of the COVID-19 pandemic. Therefore, the need for early detection of respiratory infection diseases is thought to be propelling the Middle Eastern PCR for respiratory infection diagnostics market growth during the forecast period.

Key Market Segments

Based on type, the Middle East and Africa PCR for respiratory infection diagnostics market is segmented into real time PCR (qPCR), traditional PCR, reverse-transcriptase (RT-PCR), digital PCR, multiplex PCR, and others. The real-time PCR (qPCR) segment held the largest share of the market in 2021 and is anticipated to register the highest CAGR in the market during the forecast period.

Based on product type, the Middle East and Africa PCR for respiratory infection diagnostics market is segmented into reagents and kits, instruments, and others. The reagents and kits segment held the largest share of the market in 2021 and is anticipated to register the highest CAGR in the market during the forecast period.

Based on infection type, the Middle East and Africa PCR for respiratory infection diagnostics market is segmented into bacterial infection, viral infection, and fungal & other pathogens. In 2021, viral infections segment held the largest share of the market and is estimated to register the highest CAGR in the market during the forecast period.

Based on end user, the Middle East and Africa PCR for respiratory infection diagnostics market is segmented into hospitals, physician clinics, clinical laboratories, academic and research institutions, biotech and pharma companies, and others. In 2020, clinical laboratories segment held the largest share of the market and is estimated to register the highest CAGR in the market during the forecast period.

Major Sources and Companies Listed

A few of the primary and secondary sources associated with this report on the Middle East and Africa PCR for respiratory infection diagnostics market are Centers for Disease Control and Prevention (CDC), Gulf Co-operation Council and World Health Organization (WHO).

Reasons to buy the report

• Determine prospective investment areas based on a detailed trend analysis of Middle East and Africa PCR for respiratory infection diagnostics market over the next years.
• Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
• Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
• Identify the major channels driving the Middle East and Africa PCR for respiratory infection diagnostics market, providing a clear picture of future opportunities that will help analyze, resulting in revenue expansion.
• Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Middle East and Africa PCR for respiratory infection diagnostics market.

MIDDLE EAST AND AFRICA PCR FOR RESPIRATORY INFECTION DIAGNOSTICS MARKET SEGMENTATION

By Type

• Real-Time PCR (qPCR)
• Multiplex PCR
• Traditional PCR
• Digital PCR
• Reverse-Transcriptase (RT-PCR)
• Others

By Product Type

• Reagents and Kits
• Instruments
• Others

By Infection Type

• Bacterial Infections

• • Bordetella
  • Streptococcus Pneumoniae
  • Staphylococcus Aureus
  • Haemophilus Influenzae
  • Moraxella Catarrhalis
  • Mycoplasma Pneumoniae
  • Chlamydophila Pneumoniae
  • Legionella
  • Others

• Viral Infections

• • Rhinoviruses
  • Influenza Virus
  • Severe Acute Respiratory Syndrome (SARS) CoV-2 Virus
  • Respiratory Syncytial Virus (RSV)
  • Adenovirus
  • Enterovirus
  • Parainfluenza
  • Human Metapneumovirus (hMPV)
  • Others

• Fungal and Other Pathogens

By End User

• Hospitals
• Physician Clinics
• Clinical Laboratories
• Academic and Research Institutions
• Biotech and Pharma Companies
• Others

By Country

• UAE
• South Africa
• Saudi Arabia
• Rest of Middle East and Africa

Company Profiles

• Abbott
• F. HOFFMANN-LA ROCHE LTD
• Hologic, Inc.
• BD
• BIO-RAD LABORATORIES INC.
• bioMerieux SA
• QIAGEN
• Thermo Fisher Scientific Inc.
• Seegene Inc
• AusDiagnostics

Middle East and Africa PCR for Respiratory Infection Diagnostics Market Strategic Insights

Middle East and Africa PCR for Respiratory Infection Diagnostics Market Segmentation Analysis

Middle East and Africa PCR for Respiratory Infection Diagnostics Market Report Highlights

Middle East and Africa PCR for Respiratory Infection Diagnostics Report Scope

Middle East and Africa PCR for Respiratory Infection Diagnostics Market Country and Regional Insights